Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (21-30 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|April 16, 2025
Preparation of Substituted Heterocycles and Their Use as DNA Polymerase Theta (POLQ) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 ModulatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) AntagonistsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
6-Aryl Isoindolin-1-ones: Novel mGluR2 Negative Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA ReceptorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Imidazo Pyrimidine Compounds for the Inhibition of Oncogenic KRAS Mutations in Cancer TherapyXiaoyan Li, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Cyclic Peptides Trapping Interleukin-1β to Relieve Inflammatory and Atherosclerotic Cardiovascular DiseaseQilong Hu, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Pyrido[4,3‑<i>d</i>]pyrimidine Compounds as KRAS InhibitorsJian Rong, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetryTaoqian Zhao, Steven H Liang
Pageof 27

Showing results (21-30 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|April 16, 2025
Preparation of Substituted Heterocycles and Their Use as DNA Polymerase Theta (POLQ) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 ModulatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) AntagonistsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
6-Aryl Isoindolin-1-ones: Novel mGluR2 Negative Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA ReceptorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Imidazo Pyrimidine Compounds for the Inhibition of Oncogenic KRAS Mutations in Cancer TherapyXiaoyan Li, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Cyclic Peptides Trapping Interleukin-1β to Relieve Inflammatory and Atherosclerotic Cardiovascular DiseaseQilong Hu, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Pyrido[4,3‑<i>d</i>]pyrimidine Compounds as KRAS InhibitorsJian Rong, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetryTaoqian Zhao, Steven H Liang
Pageof 27